Table 2.
Any Opioid Usea by Intervention Group and Month of Follow-Up.
| INTENT TO TREATb | AS TREATEDc | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Opioid + at | HE (n = 25) |
DT (n = 24) |
Diff (95% CI)d | HE (n = e) |
DT (n = f) |
Diff (95% CI)c |
| Month 1 | 15 (60.0%) | 14 (58.3%) | 1.7 (−25.9; 29.2) | 11 (52.4%) | 8 (44.4%) | 7.9 (−23.4; 39.3) |
| Month 2 | 14 (56.0%) | 12 (50.0%) | 6.0 (−21.9; 33.9) | 8 (42.1%) | 6 (33.3%) | 8.8 (−22.3; 39.9) |
| Month 3 | 18 (72.0%) | 15 (62.5%) | 9.5 (−16.7; 35.7) | 10 (58.8%) | 9 (50.0%) | 8.8 (−24.1; 41.7) |
a
Any self-reported opioid use or positive urine toxicology test at 1-, 2, or 3-month assessments.
b
Assumes dropouts were opioid positive.
c
Observed data from participants in the study protocol.
d
Between group difference in % testing opioid+ and 95% confidence interval estimate for the between group difference.
e
The number of available observations were 21, 19, and 17 at 1-, 2-, and 3-month assessments, respectively.
f
The number of available observations was 18 at all follow-ups..